Dear friends of Merkel cell carcinoma research, As we conclude this unprecedented year, I would like to convey Team Merkel’s appreciation of your support. Although it was a challenging year, 2020 was also one of many exciting milestones in Merkel…
Dr. Paul Nghiem, professor and head of Dermatology at the University of Washington and expert in Merkel cell carcinoma (MCC), joins the Seattle Translational Tumor Research leadership team as the Deputy Director for Skin/Cutaneous Oncology. As a hub for collaboration…
3 generations of mentor-mentees gathered in Aomori Japan at the Japanese Society for Investigative Dermatology. DOM members Drs Masaoki Kawasumi, Tomoko Akaike, and Paul Nghiem, all gave plenary session talks. Left to right: Tomoko Akaike is a Japanese dermatologist doing…
This year’s annual meeting of the Society for Investigative Dermatology took place in Chicago, Illinois from May 8-11, 2019 where members of the Nghiem Lab team had the opportunity to present their latest research. Neha Singh presented “Early baseline imaging…
Fred Hutch selected Dr. Paul Nghiem's article published in JCO "Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy." to be covered in the March 2019 issue of Science Spotlight, a monthly online publication highlighting scientific work performed…
MCC posters presented by Nghiem Lab Members at this year's SID meeting in Atlanta. - Christopher Lewis
Dr. Nghiem was appointed to the Michael W. Piepkorn Endowed Chair in Dermatology, effective October 1, 2011. Dr. Nghiem is currently Associate Professor of Medicine and Adjunct Associate Professor of Pathology, as well as an Affiliate Investigator in the Clinical Research…
Rapamycin and nutrient signaling are profiled in a review with Aly Shamji and Stuart Schreiber. [pdf]